ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors
Journal of the American College of Radiology · 2026-07 · 23 (7) · 1445-1461
DOI: 10.1016/j.jacr.2026.02.012 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the American College of Radiology, 2026-07. Verfasst von Expert Panel on Gastrointestinal Imaging und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medstar Georgetown University Hospital, Washington, District of Columbia. Electronic address: joeyacoub@gmail.com. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Diagnostic Imaging. Die Arbeit nennt 43 Literaturangaben. Gefördert von: American College of Radiology, U.S. Food and Drug Administration.
Abstract (Originalsprache)
Accurate staging and appropriate follow-up imaging of pancreatic neuroendocrine tumors (PNET) are essential for guiding management and optimizing outcomes. This document provides evidence-based recommendations for the imaging evaluation of patients with PNET across six clinical variants: local staging, staging for metastatic disease, surveillance postresection, follow-up after treatment of liver-dominant and non-liver dominant disease, and follow-up of untreated disease. Contrast-enhanced CT is usually appropriate in most scenarios and commonly used as the first-line imaging modality in assessing tumor size, locoregional extent, vascular involvement, and metastatic spread. MRI is also usually appropriate, particularly for liver evaluation. MRI with hepatobiliary contrast agents and diffusion-weighted imaging improves detection and characterization of liver metastases, especially in liver-dominant disease. DOTATATE PET/CT is usually appropriate for staging and treatment planning in patients with suspected or known metastatic disease. FDG-PET/CT is reserved for select cases, such as high-grade tumors. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer-reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medstar Georgetown University Hospital, Washington, District of Columbia. Electronic address: joeyacoub@gmail.com.
- Mayo Clinic, Scottsdale, Arizona.
- Panel Chair, Boston University Medical Center, Boston, Massachusetts.
- University of California San Francisco, San Francisco, California; American Society of Clinical Oncology.
- The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Baylor Scott & White, Baylor University Medical Center, Dallas, Texas; American Gastroenterological Association.
Förderung
- American College of Radiology
- U.S. Food and Drug Administration
Zitieren
APA
Expert Panel on Gastrointestinal Imaging, Yacoub, J. H., Yano, M., Chang, K. J., Bergsland, E., Bhosale, P. R., Cash, B. D., Chernyak, V., Gupta, A., Hallet, J., Halpern, J., Magnetta, M., Noronha, C. F., Refaat, T., & Korngold, E. K. (2026). ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors. Journal of the American College of Radiology, 23(7), 1445-1461. https://doi.org/10.1016/j.jacr.2026.02.012
Vancouver
Expert Panel on Gastrointestinal Imaging, Yacoub JH, Yano M, Chang KJ, Bergsland E, Bhosale PR, et al. ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors. Journal of the American College of Radiology. 2026;23(7):1445-1461. doi:10.1016/j.jacr.2026.02.012
BibTeX
@article{ExpertPanelonGastrointestinalImaging2026,
author = {Expert Panel on Gastrointestinal Imaging, Expert Panel on Gastrointestinal Imaging and Yacoub, Joseph H and Yano, Motoyo and Chang, Kevin J and Bergsland, Emily and Bhosale, Priya R and Cash, Brooks D and Chernyak, Victoria and Gupta, Ayushi and Hallet, Julie and Halpern, Jason and Magnetta, Michael and Noronha, Craig F and Refaat, Tamer and Korngold, Elena K},
title = {ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors},
journal = {Journal of the American College of Radiology},
year = {2026},
volume = {23},
number = {7},
pages = {1445--1461},
doi = {10.1016/j.jacr.2026.02.012}
}
EUVIMED